125 related articles for article (PubMed ID: 12800823)
1. Pulmonary hypertension and HIV.
Ball SC
AIDS Read; 2003 May; 13(5):209-10, 217-9. PubMed ID: 12800823
[No Abstract] [Full Text] [Related]
2. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
[TBL] [Abstract][Full Text] [Related]
3. Resolution of human immunodeficiency virus type 1 infection-related severe pulmonary hypertension in a very low-birth-weight infant.
Feiterna-Sperling C; Hüseman D; Timme J; Bührer C; Obladen M
Pediatr Infect Dis J; 2008 Jun; 27(6):564-7. PubMed ID: 18449067
[TBL] [Abstract][Full Text] [Related]
4. Anti-HIV agents. Should HAART begin right after an HIV diagnosis?
TreatmentUpdate; 2009; 21(3):2-3. PubMed ID: 19630120
[No Abstract] [Full Text] [Related]
5. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
Kilaru KR; Kumar A; Sippy N; Carter AO; Roach TC
HIV Med; 2006 Mar; 7(2):99-104. PubMed ID: 16420254
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary hypertension in individuals with HIV infection.
Petrosillo N; Chinello P; Cicalini S
AIDS; 2006 Oct; 20(16):2128-9. PubMed ID: 17053364
[No Abstract] [Full Text] [Related]
7. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
[TBL] [Abstract][Full Text] [Related]
8. Guidelines for diagnosis and treatment of HIV/AIDS in China (2005).
;
Chin Med J (Engl); 2006 Oct; 119(19):1589-608. PubMed ID: 17042972
[No Abstract] [Full Text] [Related]
9. Suppression of hepatitis C virus replication is maintained long term following HAART therapy, in an individual with HCV/HIV co-infection.
Torti C; Barnes E; Quiros-Roldan E; Puoti M; Carosi G; Klenerman P
Antivir Ther; 2004 Feb; 9(1):139-42. PubMed ID: 15040546
[No Abstract] [Full Text] [Related]
10. AIDS-associated Kaposi's sarcoma associated with a low viral load and a high CD4 cell count.
Stebbing J; Powles T; Bower M
AIDS; 2008 Feb; 22(4):551-2. PubMed ID: 18301078
[No Abstract] [Full Text] [Related]
11. [Disorders of pulmonary circulation].
Ogawa K; Sugioka K; Yoshiyama M
Nihon Rinsho; 2007 May; 65 Suppl 5():383-8. PubMed ID: 17571410
[No Abstract] [Full Text] [Related]
12. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
[TBL] [Abstract][Full Text] [Related]
13. Peculiar type of KS emerges in healthier individuals.
Proj Inf Perspect; 2008 Dec; (47):13-4. PubMed ID: 19230234
[No Abstract] [Full Text] [Related]
14. Anti-HIV agents. Study finds recovery of CD4+ cells may be less than expected.
TreatmentUpdate; 2003; 15(7):3-5. PubMed ID: 17216867
[No Abstract] [Full Text] [Related]
15. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
[TBL] [Abstract][Full Text] [Related]
16. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.
Kaufmann GR; Perrin L; Pantaleo G; Opravil M; Furrer H; Telenti A; Hirschel B; Ledergerber B; Vernazza P; Bernasconi E; Rickenbach M; Egger M; Battegay M;
Arch Intern Med; 2003 Oct; 163(18):2187-95. PubMed ID: 14557216
[TBL] [Abstract][Full Text] [Related]
17. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy.
Bisson GP; Gross R; Strom JB; Rollins C; Bellamy S; Weinstein R; Friedman H; Dickinson D; Frank I; Strom BL; Gaolathe T; Ndwapi N
AIDS; 2006 Aug; 20(12):1613-9. PubMed ID: 16868442
[TBL] [Abstract][Full Text] [Related]
19. Complications & side effects. HAART and bones-mixed messages.
TreatmentUpdate; 2007; 19(4):3-5. PubMed ID: 17969257
[No Abstract] [Full Text] [Related]
20. HIV-associated pulmonary hypertension.
Farber HW
AIDS Clin Care; 2001 Jun; 13(6):53-5, 59. PubMed ID: 11710309
[No Abstract] [Full Text] [Related]
[Next] [New Search]
